Evidence map›Paper›PMID 34911715›Full record

ArticleBMJ open2021

Design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya: a mixed-methods study protocol.

Melissa Latigo Mugambi, Jared M Baeten, John Kinuthia, Brett Hauber, Bryan J Weiner, Grace John-Stewart, Ruanne Vanessa Barnabas

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Melissa Latigo MugambiDepartment of Global Health, University of Washington, Seattle, Washington, USA mugambi@uw.edu.ORCID 0000-0001-8875-5528
Jared M BaetenDepartment of Global Health, University of Washington, Seattle, Washington, USA.
John KinuthiaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Brett HauberThe Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, Washington, USA.
Bryan J WeinerDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Ruanne Vanessa BarnabasDepartment of Global Health, University of Washington, Seattle, Washington, USA.
University of Washington · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
The design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settingsK01MH122326 · NIMH · UNIVERSITY OF WASHINGTON · PI MUGAMBI, MELISSA · 2021 to 2024
$582k
NIAID NIH HHS P30 AI027757NIMH NIH HHS K01 MH122326
6 · The paper itself

Abstract

introductionCommunity pharmacies play an important role in the healthcare system: they are frequently accessed and have increasing capacity to deliver HIV prevention services. In communities where the prevalence of HIV is high and access to antenatal care clinics is delayed or irregular, there is a unique opportunity to leverage pharmacies to enhance early and sustained access to HIV prevention among pregnant women. This study will identify women's preferences for delivery of HIV prevention services and provider-level and system-level strategies to design a new pharmacy-based model of care for pregnant women. The overall objective of this study is to design and evaluate strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya. METHODS AND ANALYSIS: We propose to conduct a discrete choice experiment to quantify preferences for delivery of HIV prevention interventions (including pre-exposure prophylaxis, partner testing and sexually transmitted infection screening and treatment) for pregnant women in community pharmacy settings. Latent class analysis will be used to quantify women's stated preferences and identify packages of intervention components that will optimise uptake among different subgroups of women. We will apply the Theoretical Domains Framework to identify provider-level and system-level factors that might influence the implementation of the optimal intervention packages. We will then use the Behaviour Change Wheel and survey a panel of experts to select and gain consensus on strategies to improve implementation. Finally, we will evaluate the potential costs of extending the implementation of HIV prevention interventions from the clinic to community pharmacy settings. ETHICS AND DISSEMINATION: The protocol was approved by the Kenyatta National Hospital-University of Nairobi Ethics Research Committee and the University of Washington Institutional Review Board. The results of this research will be published in peer-reviewed journals and shared with various stakeholders, including community members, policymakers and researchers, through local and international conferences.

Indexed as

HIV InfectionsPharmaciesPre-Exposure ProphylaxisFemaleHumansKenyaPregnancyPregnant Peoplehealth economicsHIV & AIDSmaternal medicineorganisation of health servicesqualitative research

Identifiers

PMID34911715
PMCPMC8679098
OpenAlexW4200146670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.